|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lee SI and Atri M: 2018 FIGO staging
system for uterine cervical cancer: Enter cross-sectional imaging.
Radiology. 292:15–24. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cho H, Oh CK, Cha J, Chung JI, Byun SS,
Hong SK, Chung JS and Han KH: Association of serum
prostate-specific antigen (PSA) level and circulating tumor
cell-based PSA mRNA in prostate cancer. Prostate Int. 10:14–20.
2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nieder C, Dalhaug A and Mannsåker B:
Established serum biomarkers are prognostic factors in patients
with oligometastatic cancer and brain involvement. In Vivo.
36:801–805. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
López-Aguilar JE, Velázquez-Flores MA,
Simón-Martínez LA, Ávila-Miranda R, Rodríguez-Florido MA and
Ruiz-Esparza Garrido R: Circulating microRNAs as biomarkers for
pediatric astrocytomas. Arch Med Res. 48:323–332. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zheng S, Li R, Liang J, Wen Z, Huang X, Du
X, Dong S, Zhu K, Chen X, Liu D, et al: Serum miR-638 combined with
squamous cell carcinoma-related antigen as potential screening
biomarkers for cervical squamous cell carcinoma. Genet Test Mol
Biomarkers. 24:188–194. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jia W, Wu Y, Zhang Q, Gao GE, Zhang C and
Xiang Y: Expression profile of circulating microRNAs as a promising
fingerprint for cervical cancer diagnosis and monitoring. Mol Clin
Oncol. 3:851–858. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Qiu H, Liang D, Liu L, Xiang Q, Yi Z and
Ji Y: A novel circulating MiRNA-based signature for the diagnosis
and prognosis prediction of early-stage cervical cancer. Technol
Cancer Res Treat. 19(1533033820970667)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
ACCP. Pap smears: An important but
imperfect method. Cervical Cancer Prevention Fact Sheet, 2002.
|
|
10
|
Milla Villeda RH, Alvarado Zaldívar G,
Sánchez Anguiano LF, Barrera Tovar M and Vázquez Arreola I:
Colposcopy and cervical biopsy in patients with routine
Papanicolaou smear. Ginecol Obstet Mex. 65:235–238. 1997.PubMed/NCBI
|
|
11
|
Chu E, Bratwaite O, Gonzalez I, Campo Z
and De León RG: Diagnosis of human papillomavirus by Papanicolau
and PCR in a group of adolescents and young women. Instituto
conmemorativo gorgas de estudios de la salud, centro de
investigación en reproducción humana. URL: Microsoft
Word-2087_2002_doc(gorgas.gob.pa).
|
|
12
|
Flores-Juárez DJ and García-González GA:
Usefulness of Papanicolau for cervical dysplasia in patients HPV
positive with CD4 <200 cell/mm3. Escuela de Estudios de
Postgrado de la Facultad de Ciencias Médicas Maestría en
Ginecología y Obstetricia Tesis para obtener el grado de Maestras
en Ciencias en Ginecología y Obstetricia, pp1-45, 2014. URL:
https://biblioteca.medicina.usac.edu.gt/tesis/post/2014/071.pdf.
|
|
13
|
Terrádez Raro JJ, Coloma Colomer F,
Navarro Conde P and Gasull Ibáñez J: Cervical cancer screening in
public health system in Valencia community and Pap test limit. Rev
ESP Patol. 38:3–7. 2005.
|
|
14
|
Dzul-Rosado KR, Puerto-Solís M and
González Losa MR: Cáncer cervicouterino: Métodos actuales para su
detección. Rev Biomed. 15:233–241. 2004.
|
|
15
|
Vlastos AT, Richards-Kortum R, Zuluaga A
and Follen M: New approaches to cervical cancer screening.
Contemporary Ob/Gyn. 47:87–107. 2002.
|
|
16
|
Andrade AZ, Zaragoza JZ, Blanco BR and
Marañón RT: Evaluación del papanicolaou y la colposcopia en el
diagnóstico de la infección por el virus del papiloma humano. Rev
Fac Med UNAM. 44:5–7. 2001.
|
|
17
|
Granados-García V, Flores YN, Pérez R,
Rudolph SE, Lazcano-Ponce E and Salmerón J: Cost of the cervical
cancer screening program at the mexican social security institute.
Salud Publica Mex. 56:502–510. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Solares LF, Álvarez AM, García-Echeverría
AM and Velasco MJ: Diagnóstico citológico de ASCUS. Identificación
del riesgo para displasia cervical mediante test del virus del
papiloma humano. Clin Invest Ginecol Obstet. 32:50–53. 2005.
|
|
19
|
Zhang Q, Kuhn L, Denny LA, De Souza M,
Taylor S and Wright TC Jr: Impact of utilizing p16INK4A
immunohistochemistry on estimated performance of three cervical
cancer screening tests. Int J Cancer. 120:351–356. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mattosinho de Castro Ferraz Mda G, Nicolau
SM, Stávale JN, Focchi J, Castelo A, Dôres GB, Mielzynska-Lohnas I,
Lorincz A and Rodrigues de Lima G: Cervical biopsy-based comparison
of a new liquid-based thin-layer preparation with conventional Pap
smears. Diagn Cytopathol. 30:220–226. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Mitsuhashi A, Matsui H, Usui H, Nagai Y,
Tate S, Unno Y, Hirashiki K, Seki K and Shozu M: Serum YKL-40 as a
marker for cervical adenocarcinoma. Ann Oncol. 20:71–77.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu G, Fan W, Wang F, Lu H, Xing X, Zhang R
and Jiang P: CTHRC1 as a novel biomarker in the diagnosis of
cervical squamous cell carcinoma. Int J Clin Exp Pathol.
11:847–854. 2018.PubMed/NCBI
|
|
23
|
Yang SH, Wang XL, Cai J and Wang SH:
Diagnostic value of circulating PIGF in combination with Flt-1 in
early cervical cancer. Curr Med Sci. 40:973–978. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sidorkiewicz I, Zbucka-Krętowska M, Zaręba
K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E and Ławicki S:
Plasma levels of M-CSF and VEGF in laboratory diagnostics and
differentiation of selected histological types of cervical cancers.
BMC Cancer. 19(398)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ning R, Meng S, Wang L, Jia Y, Tang F, Sun
H, Zhang Z, Zhang C, Fan X, Xiao B, et al: 6 Circulating miRNAs can
be used as non-invasive biomarkers for the detection of cervical
lesions. J Cancer. 12:5106–5113. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen J, Yao D, Li Y, Chen H, He C, Ding N,
Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression
levels can predict lymph node metastasis in patients with
early-stage cervical squamous cell carcinoma. Int J Mol Med.
32:557–567. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sun W, Wang L, Zhao D, Wang P, Li Y and
Wang S: Four circulating long non-coding RNAs Act as biomarkers for
predicting cervical cancer. Gynecol Obstet Invest. 83:533–539.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang WJ, Wang D, Zhao M, Sun XJ, Li Y, Lin
H, Che YQ and Huang CZ: Serum lncRNAs (CCAT2, LINC01133, LINC00511)
with squamous cell carcinoma antigen panel as novel non-invasive
biomarkers for detection of cervical squamous carcinoma. Cancer
Manag Res. 12:9495–9502. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Rungkamoltip P, Temisak S, Piboonprai K,
Japrung D, Thangsunan P, Chanpanitkitchot S, Chaowawanit W,
Chandeying N, Tangjitgamol S and lempridee T: Rapid and
ultrasensitive detection of circulating human papillomavirus E7
cell-free DNA as a cervical cancer biomarker. Exp Biol Med
(Maywood). 246:654–666. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gadducci A, Tana R, Cosio S and Genazzani
AR: The serum assay of tumour markers in the prognostic evaluation,
treatment monitoring and follow-up of patients with cervical
cancer: A review of the literature. Crit Rev Oncol Hematol.
66:10–20. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Duffy MJ: Evidence for the clinical use of
tumor markers. Ann Clin Biochem. 41:370–377. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Uemera Y, Pak SC, Luke C, Cataltepec S,
Tsu C, Schick C, Kamachi Y, Pomeroy SL, Perlmutter DH and Silverman
GA: Circulating serpin tumor markers SCCA1 and SCCA2 are not
actively secreted but reside in the cytosol of squamous carcinoma
cells. Int J Cancer. 89:368–377. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Numa F, Takeda O, Nakata M, Nawata S,
Tsunaga N, Hirabayashi K, Suminami Y, Kato H and Hamanaka S: Tumor
necrosis factor-alpha stimulates the production of squamous cell
carcinoma antigen in normal squamous cells. Tumour Biol. 17:97–101.
1996.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liposits G, Skuladottir H, Ryg J, Winther
SB, Möller S, Hofsli E, Shah CH, Poulsen LØ, Berglund Å, Qvortrup
C, et al: The prognostic value of pre-treatment circulating
biomarkers of systemic inflammation (CRP, dNLR, YKL-40, and IL-6)
in vulnerable older patients with metastatic colorectal cancer
receiving palliative chemotherapy-the randomized NORDIC9-study. J
Clin Med. 11(5603)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Dolin TG, Christensen IJ, Lund CM, Bojesen
SE, Lykke J, Nielsen DL, Larsen JS and Johansen JS: Preoperative
plasma vitamin D in patients with localized colorectal cancer:
Age-dependent association with inflammation, postoperative
complications, and survival. Eur J Surg Oncol.
(S0748-7983(22)00651-5)2022.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
36
|
Rathcke CN and Vestergaard H: YKL-40, a
new inflammatory marker with relation to insulin resistance and
with a role in endothelial dysfunction and atherosclerosis. Inflamm
Res. 55:221–227. 2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bao J, Ouyang Y, Qiao L, He J, Liu F, Wang
Y, Miao L, Fu A, Lou Z, Zang Q, et al: Serum CHI3L1 as a biomarker
for non-invasive diagnosis of liver fibrosis. Discov Med. 33:41–49.
2022.PubMed/NCBI
|
|
38
|
Shi M, Ge Q, Wang X, Diao W, Yang B, Sun
S, Wang G, Liu T, Chan AML, Gao Z, et al: Functional analysis of
the short splicing variant encoded by CHI3L1/YKL-40 in
glioblastoma. Front Oncol. 12(910728)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Videmark AN, Christensen IJ, Feltoft CL,
Villadsen M, Borg FH, Jørgensen BM, Bojesen SE, Kistorp C,
Ugleholdt R and Johansen JS: Combined plasma C-reactive protein,
interleukin 6 and YKL-40 for detection of cancer and prognosis in
patients with serious nonspecific symptoms and signs of cancer.
Cancer Med: Nov 28, 2022 (Epub ahead of print).
|
|
40
|
Hermunen K, Soveri LM, Boisen MK, Mustonen
HK, Dehlendorff C, Haglund CH, Johansen JS and Osterlund P:
Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination
with CEA as prognostic markers for recurrence and survival in
colorectal cancer. Acta Oncol. 59:1416–1423. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Sheng X, Du X, Zhang X, Li D, Lu C, Li Q,
Ma Z, Song Q and Wang C: Clinical value of serum HMGB1 levels in
early detection of recurrent squamous cell carcinoma of uterine
cervix: Comparison with serum SCCA, CYFRA21-1, and CEA levels.
Croat Med J. 50:455–464. 2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chen Y, Xiong X, Wang Y, Zhao J, Shi H,
Zhang H, Wang Y, Wei Y, Xue W and Zhang J: Proteomic screening for
serum biomarkers for cervical cancer and their clinical
significance. Med Sci Monit. 25:288–297. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhu B, Dong B, Hong S, Wang M, Dai W,
Zheng Q, Wu D and Cao Y: Combined detection of ACTN4 and SCC-Ag is
a promising serological biomarker for cervical intraepithelial
neoplasia 3 or worse: A case-control study. Risk Manag Health
Policy. 13:2677–2687. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
Initial sequencing and analysis of the human genome. Nature.
409:860–921. 2001.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang F, Sun H, Li K, Yang K, Xiang Y and
Tian X: CircRASSF2 promotes IGF1R and osteosarcoma metastasis via
sponging miR-6838-5p. Ann Transl Med. 10(11)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gupta A, Vats A, Ghosal A, Mandal K,
Sarkar R, Bhattacharya I, Das S, Pal R and Majumdar SS:
Follicle-stimulating hormone-mediated decline in miR-92a-3p
expression in pubertal mice Sertoli cells is crucial for germ cell
differentiation and fertility. Cell Mol Life Sci.
79(136)2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bartel DP: Metazoan MicroRNAs. Cell.
173:20–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hansen TB, Venø MT, Jensen TI, Schaefer A,
Damgaard CK and Kjems J: Argonaute-associated short introns are a
novel class of gene regulators. Nat Commun. 7(11538)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Vincent K, Pichler M, Lee GW and Ling H:
MicroRNAs, genomic instability and cancer. Int J Mol Sci.
15:14475–14491. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liu H, Lei C, He Q, Pan Z, Xiao D and Tao
Y: Nuclear functions of mammalian MicroRNAs in gene regulation,
immunity and cancer. Mol Cancer. 17(64)2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Leucci E, Patella F, Waage J, Holmstrøm K,
Lindow M, Porse B, Kauppinen S and Lund AH: microRNA-9 targets the
long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep.
3(2535)2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zitzer NC, Garzon R and Ranganathan P:
Toll-like receptor stimulation by MicroRNAs in acute graft-vs-host
disease. Front Immunol. 9(2561)2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhao S, Yao D, Chen J and Ding N:
Circulating miRNA-20a and miRNA-203 for screening lymph node
metastasis in early stage cervical cancer. Genet Test Mol
Biomarkers. 17:631–636. 2013.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Ma Q, Wan G, Wang S, Yang W, Zhang J and
Yao X: Serum microRNA-205 as a novel biomarker for cervical cancer
patients. Cancer Cell Int. 14(81)2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kong Q, Tang Z, Xiang F, Jiang J, Yue H,
Wu R and Kang X: Diagnostic value of serum hsa-mir-92a in patients
with cervical cancer. Clin Lab. 63:335–340. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Hoelzle CR, Arnoult S, Borém CRM, Ottone
M, de Magalhaes KCSF, da Silva IL and Simoes RT: MicroRNA levels in
cervical cancer samples and relationship with lesion grade and HPV
infection. Microrna. 10:139–145. 2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Zhang Y, Qiu S, Guo Y, Zhang J, Wu X and
Hong G: Diagnostic value of vaginal microecology, serum miR-18a,
and PD-L1 for identifying HPV-positive cervical cancer. Technol
Cancer Res Treat. 20(1533033821995281)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Cai Y, Zhang K, Cao L, Sun H and Wang H:
Inhibition of microrna-766-5p attenuates the development of
cervical cancer through regulating SCAI. Technol Cancer Res Treat.
19(1533033820980081)2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ocadiz-Delgado R, Lizcano-Meneses S,
Trejo-Vazquez JA, Conde-Perezprina JC, Garrido-Palmas F,
Alvarez-Rios E, García-Villa E, Ruiz G, Illades-Aguiar B,
Leyva-Vázquez MA, et al: Circulating miR-15b, miR-34a and miR-218
as promising novel early low-invasive biomarkers of cervical
carcinogenesis. APMIS. 129:70–79. 2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Yang D and Zhang Q: miR-152 may function
as an early diagnostic and prognostic biomarker in patients with
cervical intraepithelial neoplasia and patients with cervical
cancer. Oncol Lett. 17:5693–5698. 2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ding N, Lu Y, Zhu SL, Zhao S, Chen JY, He
CJ, Ren F and Yao DS: MiR-17 promotes cervical squamous cell
tumorigenesis and metastasis by targeting E2F1. Int J Clin Exp
Pathol. 9:10224–10232. 2016.
|
|
63
|
Shukla V, Varghese VK, Kabekkodu SP,
Mallya S, Chakrabarty S, Jayaram P, Pandey D, Banerjee S, Sharan K
and Satyamoorthy K: Enumeration of deregulated miRNAs in liquid and
tissue biopsies of cervical cancer. Gynecol Oncol. 155:135–143.
2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Pulati N, Zhang Z, Gulimilamu A, Qi X and
Yang J: HPV16+ -miRNAs in cervical cancer and the
anti-tumor role played by miR-5701. J Gene Med.
21(e3126)2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Zhou CF, Ma J, Huang L, Yi HY, Zhang YM,
Wu XG, Yan RM, Liang L, Zhong M, Yu YH, et al: Cervical squamous
cell carcinoma-secreted exosomal miR-221-3p promotes
lymphangiogenesis and lymphatic metastasis by targeting VASH1.
Oncogene. 38:1256–1268. 2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Zhu X, Long L, Xiao H and He X:
Cancer-derived exosomal miR-651 as a diagnostic marker restrains
cisplatin resistance and directly targets ATG3 for cervical cancer.
Dis Markers. 2021(1544784)2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Yamanaka Z, Sasaki T, Yamanaka A, Kato K
and Nishi H: Circulating and tissue miR-100 acts as a potential
diagnostic biomarker for cervical cancer. Cancer Biomark.
32:551–558. 2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Lv A, Tu Z, Huang Y, Lu W and Xie B:
Circulating exosomal miR-125a-5p as a novel biomarker for cervical
cancer. Oncol Lett. 21(54)2021.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zheng M, Hou L, Ma Y, Zhou L, Wang F,
Cheng B, Wang W, Lu B, Liu P, Lu W and Lu Y: Exosomal let-7d-3p and
miR-30d-5p as diagnostic biomarkers for non-invasive screening of
cervical cancer and its precursors. Mol Cancer.
18(76)2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Zhang Y, Zhang D, Wang F, Xu D, Guo Y and
Cui W: Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497)
as novel non-invasive biomarkers for detection of cervical cancer.
Sci Rep. 5(17942)2015.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Xin F, Liu P and Ma CF: A circulating
serum miRNA panel as early detection biomarkers of cervical
intraepithelial neoplasia. Eur Rev Med Pharmacol Sci. 20:4846–4851.
2016.PubMed/NCBI
|
|
72
|
Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y,
Chen YQ and Hong SJ: Differentially expressed microRNAs in the
serum of cervical squamous cell carcinoma patients before and after
surgery. J Hematol Oncol. 7(6)2014.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Subhash S, Mishra K, Akhade VS, Kanduri M,
Mondal T and Kanduri C: H3K4me2 and WDR5 enriched chromatin
interacting long non-coding RNAs maintain transcriptionally
competent chromatin at divergent transcriptional units. Nucleic
Acids Res. 46:9384–9400. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Montero JJ, López-Silanes I, Megías D, F
Fraga M, Castells-García Á and Blasco MA: TERRA recruitment of
polycomb to telomeres is essential for histone trymethylation marks
at telomeric heterochromatin. Nat Commun. 9(1548)2018.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Li J, Wang Y, Yu J, Dong R and Qiu H: A
high level of circulating HOTAIR is associated with progression and
poor prognosis of cervical cancer. Tumour Biol. 36:1661–1665.
2015.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Catanzaro JM, Guerriero JL, Liu J, Ullman
E, Sheshadri N, Chen JJ and Zong WX: Elevated expression of
squamous cell carcinoma antigen (SCCA) is associated with human
breast carcinoma. PLoS One. 6(e19096)2011.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Qiao D, Qin X, Yang H, Liu X, Liu L, Liu S
and Jia Z: Estradiol mediates the interaction of LINC01541 and
miR-429 to promote angiogenesis of G1/G2 endometrioid
adenocarcinoma in-vitro: A pilot study. Front Oncol.
12(951573)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Lu Z, Zhang Y, Yan X, Chen Y, Tao X, Wang
J, Jia N, Lyu T, Wang J, Ding J, et al: Estrogen stimulates the
invasion of ovarian cancer cells via activation of the PI3K/AKT
pathway and regulation of its downstream targets E-cadherin and
α-actinin-4. Mol Med Rep. 10:2433–2440. 2014.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Liu L, Liu S, Luo H, Chen C, Zhang X, He L
and Tu G: GPR30-mediated HMGB1 upregulation in CAFs induces
autophagy and tamoxifen resistance in ERα-positive breast cancer
cells. Aging (Albany NY). 13:16178–16197. 2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Johansen JS, Brasso K, Iversen P, Teisner
B, Garnero P, Price PA and Christensen IJ: Changes of biochemical
markers of bone turnover and YKL-40 following hormonal treatment
for metastatic prostate cancer are related to survival. Clin Cancer
Res. 13:3244–3249. 2007.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Hu X, Wang Q, Zhao H, Wu W, Zhao Q, Jiang
R, Liu J, Wang L and Yuan P: Role of miR-21-5p/FilGAP axis in
estradiol alleviating the progression of monocrotaline-induced
pulmonary hypertension. Animal Model Exp Med. 5:217–226.
2022.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Mandel P and Métais P: Les acides
nucléiques du plasma sanguin chez l'homme. C R Seances Soc Biol Ses
Fil. 142:241–243. 1948.PubMed/NCBI
|
|
84
|
Leon SA, Shapiro B, Sklaroff DM and Yaros
MJ: Free DNA in the serum of cancer patients and the effect of
therapy. Cancer Res. 37:646–650. 1977.PubMed/NCBI
|
|
85
|
Schwarzenbach H, Hoon DSB and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al:
Detection of circulating tumor DNA in early- and late-stage human
malignancies. Sci Transl Med. 6(224ra24)2014.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Kustanovich A, Schwartz R, Peretz T and
Grinshpun A: Life and death of circulating cell-free DNA. Cancer
Biol Ther. 20:1057–1067. 2019.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Wang W, Kong P, Ma G, Li L, Zhu J, Xia T,
Xie H, Zhou W and Wang S: Characterization of the release and
biological significance of cell-free DNA from breast cancer cell
lines. Oncotarget. 8:43180–43191. 2017.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Trejo-Becerril C, Pérez-Cárdenas E,
Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velázquez LA,
Hidalgo-Miranda A, Pérez-Montiel D, Chávez-Blanco A, Cruz-Velázquez
J, et al: Cancer progression mediated by horizontal gene transfer
in an in vivo model. PLoS One. 7(e52754)2012.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Marsman G, Zeerleder S and Luken BM:
Extracellular histones, cell-free DNA, or nucleosomes: Differences
in immunostimulation. Cell Death Dis. 7(e2518)2016.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Takahashi A, Okada R, Nagao K, Kawamata Y,
Hanyu A, Yoshimoto S, Takasugi M, Watanabe S, Kanemaki MT, Obuse C
and Hara E: Exosomes maintain cellular homeostasis by excreting
harmful DNA from cells. Nat Commun. 8(15287)2017.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Pornthanakasem W, Shotelersuk K,
Termrungruanglert W, Voravud N, Niruthisard S and Mutirangura A:
Human papillomavirus DNA in plasma of patients with cervical
cancer. BMC Cancer. 1(2)2001.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Guan T, Guo XY, Ye CL and Jiang YH:
Analysis of circulating DNA level in the plasma of cervical cancer
patients. Nan Fang Yi Ke Da Xue Xue Bao. 28:1663–1664, 1667.
2008.PubMed/NCBI(In Chinese).
|
|
94
|
Yang HJ, Liu VWS, Tsang PCK, Yip AMW, Tam
KF, Wong LC, Ng TY and Ngan HYS: Quantification of human
papillomavirus DNA in the plasma of patients with cervical cancer.
Int J Gynecol Cancer. 14:903–910. 2004.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Venezuela RF, Kiguen AX, Frutos MC and
Cuffini CG: Circulation of human papillomavirus (HPV) genotypes in
women from Córdoba, Argentina, with squamous intraepithelial
lesions. Rev Inst Med Trop Sao Paulo. 54:11–16. 2012.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Campitelli M, Jeannot E, Peter M,
Lappartient E, Saada S, de la Rochefordière A, Fourchotte V, Alran
S, Petrow P, Cottu P, et al: Human papillomavirus mutational
insertion: Specific marker of circulating tumor DNA in cervical
cancer patients. PLoS One. 78(e43393)2012.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Han K, Leung E, Barbera L, Barnes E, Croke
J, Di Grappa MA, Fyles A, Metser U, Milosevic M, Pintilie M, et al:
Circulating human papillomavirus DNA as a biomarker of response in
patients with locally advanced cervical cancer treated with
definitive chemoradiation. JCO Precis Oncol. 2:1–8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Cabel L, C Bonneau C, Bernard-Tessier A,
Héquet D, Tran-Perennial C, Bataillon G, Rouzier R, Féron JG,
Fourchotte V, Le Brun JF, et al: HPV ctDNA detection of high-risk
HPV types during chemoradiotherapy for locally advanced cervical
cancer. ESMO Open. 6(100154)2021.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Tian X, Ge D, Zhang F, Zhang B, Bai W, Xu
X, Li Z, Cao Y, Li P, Zou K and Zou L: Dynamic analysis of
circulating tumor DNA to predict prognosis and monitor therapeutic
response in metastatic relapsed cervical cancer. Int J Cancer.
148:921–931. 2021.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Fabbri M, Paone A, Calore F, Galli R,
Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al:
MicroRNAs bind to Toll-like receptors to induce prometastatic
inflammatory response. Proc Natl Acad Sci USA. 109:E2110–E2116.
2012.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Quillien V, Raoul JL, Laurent JF, Meunier
B and Le Prise E: Comparison of Cyfra 21-1, TPA and SCC tumor
markers in esophageal squamous cell carcinoma. Oncol Rep.
5:1561–1565. 1998.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Bi H, Yin L, Fang W, Song S, Wu S and Shen
J: Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with
clinicopathological characteristics and chemotherapeutic outcomes
of lung cancer. Lab Med: lmac122, 2022 (Epub ahead of print).
|
|
103
|
Fatica EM, Larson BJ, Algeciras-Schimnich
A and Bornhorst JA: Performance characteristics of the BRAHMS
KRYPTOR automated squamous cell carcinoma antigen assay. J Immunol
Methods. 504(113257)2022.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Petrelli NJ, Shaw N, Bhargava A, Daufeldt
J, Herrera L, Stulc JP, Sischy B and Mittelman A: Squamous cell
carcinoma antigen as a marker for squamous cell carcinoma of the
anal canal. J Clin Oncol. 6:782–785. 1988.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Kommu S, Hadway P and Watkin N: Squamous
cell carcinoma antigen as a biomarker for penile cancer. BJU Int.
95:478–479. 2005.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Huang R, Yao J, Ding X, Liu J, Fan C, Duan
H and Ye H: Plasma YKL-40: A potential biomarker for tumor invasion
in esophageal cancer. Clin Lab. 66:2020.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Tomas C, Risteli J, Risteli L, Stenback F
and Kauppila A: Measurement of epithelial and stromal changes in
vulvar carcinoma-a clinical, biochemical and immunohistochemical
study. Int J Oncol. 7:101–105. 1995.PubMed/NCBI
|
|
108
|
Kannan A, Hertweck KL, Philley JV, Wells
RB and Dasgupta S: Genetic mutation and exosome signature of human
papilloma virus associated oropharyngeal cancer. Sci Rep.
7(46102)2017.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Zhang T, Liu Q, Yu M, Lan Y and Zhou J:
Expression profiles reveal involvement of VEGF, IGF1, BIRC5, and
MMP1 in vulvar carcinogenesis. Technol Cancer Res Treat.
20(15330338211004922)2021.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Ramqvist T, Näsman A, Franzén B, Bersani
C, Alexeyenko A, Becker S, Haeggblom L, Kolev A, Dalianis T and
Munck-Wikland E: Protein expression in tonsillar and base of tongue
cancer and in relation to human papillomavirus (HPV) and clinical
outcome. Int J Mol Sci. 19(978)2018.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Lassig AAD, Joseph AM, Lindgren BR and
Yueh B: Association of oral cavity and oropharyngeal cancer
biomarkers in surgical drain fluid with patient outcomes. JAMA
Otolaryngol Head Neck Surg. 143:670–678. 2017.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Emmett SE, Stark MS, Pandeya N, Panizza B,
Whiteman DC and Antonsson A: MicroRNA expression is associated with
human papillomavirus status and prognosis in mucosal head and neck
squamous cell carcinomas. Oral Oncol. 113(105136)2021.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Weiss BG, Anczykowski MZ, Ihler F,
Bertlich M, Spiegel JL, Haubner F, Canis M, Küffer S, Hess J, Unger
K, et al: MicroRNA-182-5p and microRNA-205-5p as potential
biomarkers for prognostic stratification of p16-positive
oropharyngeal squamous cell carcinoma. Cancer Biomark. 33:331–347.
2022.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Zhang J, Liu SC, Luo XH, Tao GX, Guan M,
Yuan H and Hu DK: Exosomal long noncoding RNAs are differentially
expressed in the cervicovaginal lavage samples of cervical cancer
patients. J Clin Lab Anal. 30:1116–1121. 2016.PubMed/NCBI View Article : Google Scholar
|
